Guilin Sanjin Pharmaceutical gets approval to start clinical trial for injection
Thursday, August 11, 2016
Guilin Sanjin Pharmaceutical Co Ltd Says it got approval from State Food and Drug Administration to start clinical trial for the injection(No. 2016L06884).
Says the injection is for the treatment of colorectal cancer as well as head and neck cancer.
Source : reuters.com
